Dr. Humphrey on Mogamulizumab for Cutaneous T-Cell Lymphoma

1 Visningar
administrator
administrator
08/09/23

Jeffrey Humphrey, MD, president, Kyowa Hakko Kirin Pharma, Inc., discusses the benefits of mogamulizumab for the treatment of cutaneous T-cell lymphoma.

  • Kategori

Visa mer

0 Kommentarer Sortera efter

Inga kommentarer hittades

Facebook-kommentarer

Strax